Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.43 |
| ▸ | MAOA | P21397 | 7/20 | 0.43 |
| ▸ | HTR2C | P28335 | 7/20 | 0.43 |
| ▸ | KDM1A | O60341 | 5/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134488 | 1.00 | MAOB (0.43) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL5016297 | 1.00 | MAOB (0.43) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL1870104 | 1.00 | MAOB (0.43) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL2160352 | 1.00 | MAOB (0.43) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL12143680 | 1.00 | MAOB (0.43) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL7731515 | 0.90 | MAOB (0.36) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL7731519 | 0.90 | MAOB (0.36) | MAOBMAOAHTR2CKDM1ACYP2C19 | |
| SCHEMBL10527956 | 0.81 | FFAR1 (0.41) | HTR2CCYP2C19CYP1A2CYP2C9CYP3A4 | |
| SCHEMBL10529544 | 0.81 | SLC9A1 (0.41) | HTR2CSLC6A2SLC6A3SLC9A1HTR2B | |
| SCHEMBL10529540 | 0.81 | SLC9A1 (0.41) | HTR2CSLC6A2SLC6A3SLC9A1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080467-A | Preparation method of high-temperature high-energy-storage polyimide dielectric film modified based on porphyrin crosslinking agent | — | 2026-05-26 | — | — | CN | claimed |
| CN-107743524-B | Method for prognosis of prostate cancer | 皇家飞利浦有限公司 | 2022-10-28 | — | — | CN | claimed |
| EP-1754705-A2 | Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders | Genentech, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| CN-122080467-A | Preparation method of high-temperature high-energy-storage polyimide dielectric film modified based on porphyrin crosslinking agent | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122080467-A | Preparation method of high-temperature high-energy-storage polyimide dielectric film modified based on porphyrin crosslinking agent | — | 2026-05-26 | — | — | CN | disclosed |
| CN-121925441-A | Preparation of hydrophobic, mechanically flexible and optically transparent polyimide aerogel | 多伦多大学管理委员会 | 2026-04-24 | — | — | CN | disclosed |
| US-12365764-B2 | Fabrication of hydrophobic, mechanically flexible and optically transparent polyimide aerogels | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-07-22 | — | — | US | disclosed |
| US-12365764-B2 | Fabrication of hydrophobic, mechanically flexible and optically transparent polyimide aerogels | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-07-22 | — | — | US | disclosed |
| EP-4559918-A2 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | Genzyme Corporation (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3673906-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORP (US) | 2025-05-14 | — | — | EP | disclosed |
| US-20250145561-A1 | 4-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88 | RESEARCH TRIANGLE INSTITUTE (US) | 2025-05-08 | — | — | US | disclosed |
| US-4845122-A | HAY FEVER, RHINITIS, ASTHMA | DYMAS FUNDING COMPANY, LLC, AS AGENT | 1989-07-04 | — | — | US | disclosed |
| US-4499149-A | ADHESION; HEAT RESISTANCE; PROTECTIVE COATINGS; SEMICONDUCTORS; POLYIMIDES | M&T CHEMICALS INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-4480009-A | POLYIMIDE, POLYAMIDEIMIDE, OR POLY-HALF-AMIDE | M&T CHEMICALS INC. (US) | 1984-10-30 | — | — | US | disclosed |
| EP-0054426-A2 | Improvements in or relating to siloxanes | M & T CHEMICALS, INC. (US) | 1982-06-23 | — | — | EP | disclosed |
| US-4158672-A | OIL AND WATER REPELLENTS FOR TEXTILES | CIBA-GEIGY CORPORATION (US) | 1979-06-19 | — | — | US | disclosed |
| US-4097642-A | URETHANE-CONTAINING | CIBA-GEIGY CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
| US-4054592-A | Urethanes containing two perfluoroalkylthio groups | CIBA-GEIGY CORPORATION (US) | 1977-10-18 | — | — | US | disclosed |
| US-4001305-A | POLYURETHANES, OIL AND WATER REPELLANT, MOLD-RELEASE | CIBA-GEIGY CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3935277-A | OIL AND WATER REPELLENT INTERMEDIATES | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145561-A1 | 4-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88 | GPR88, GPR84, GPR139 | MAOB 1329/4885MAOA 727/4885HTR2C 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.